Vox Markets Interview with Avacta CEO Alastair Smith

0 Görünümler· 09/19/23
The Vox Markets Podcast
0
İçinde

Following today’s “stunning” safety & efficacy data wrt Avacta's AVA6000 phase 1a clinical trial, I was delighted to catchup again with CEO Alastair Smith, who took me through the hugely significant news.

Daha fazla göster

 0 Yorumlar sort   Göre sırala


Bir sonraki